Valois Acquires New Inhaler

Valois Pharmaceutical Division (Marly-le-Roi, France) has acquired the rights to a dry powder inhaler from Quadrant Technologies Ltd. With this acquisition, the company has expanded its pulmonary franchise. 

The device is a multidose inhaler based on a blister-type powder storage system. This system provides advanced moisture protection for the drug and high fine-particle fraction performance. According to Olivier Fourment, president of Valois, the technology complements the firm�s metering valves used for pressurized metered dose inhalers. �It will allow us to strengthen our leading position in pulmonary drug delivery devices and offer pharmaceutical and biotechnology companies a portfolio of technologies to meet their pulmonary drug delivery needs,� he said. 

Valois has also secured the services of Quadrant Drug Delivery for the development of dry powder formulations suitable for the inhaler. 


No votes yet